VYNE Therapeutics Inc. — SEC S-4 Filing
HealthcareNew JerseyOther
Yarrow Bioscience→Shanghai Scizeng Medical Technology
Mar 31, 2026
Healthcare M&A Deals in New Jersey
24 dealsTracking 24 healthcare M&A deals in New Jersey. Recent activity spans Pharmacy, Healthcare Services Other, Medical Devices, Pharmaceuticals. New Jersey ranks #4 of 41 states for healthcare deal volume.
Merck to Boost Oncology Pipeline With $6.7B Terns Buyout, Stock Up - TradingView
HealthcareNew JerseyPlatform
Merck→Terns Pharmaceuticals
Mar 26, 2026
Embecta Corp. — SEC 8-K Filing
HealthcareNew JerseyMerger
Embecta→Owen Mumford Holdings
Mar 20, 2026
LISATA THERAPEUTICS, INC. — SEC 8-K Filing
HealthcareNew JerseyMerger
Kuva Labs→Lisata Therapeutics
Mar 9, 2026